Exploring the Role of DPF1 in Hepatocellular Carcinoma: Implications for Prognosis and Therapy
Our study reveals that DPF1 is a novel prognostic biomarker in HCC, with potential implications for immunotherapy and drug resistance. Elevated DPF1 expression is associated with adverse clinical outcomes and may serve as a target for future therapeutic interventions in HCC.
Authors
- Niansong Qian (ORCID: https://orcid.org/0000-0002-3297-4294)
- Yinyi Li (ORCID: https://orcid.org/0009-0003-8441-5499)
- Mei Sun (ORCID: https://orcid.org/0000-0003-0276-0612)
- Fan Yang (ORCID: https://orcid.org/0000-0003-2926-4686)
- Dongbing Li (ORCID: https://orcid.org/0000-0002-5227-9643)
- Dan Chen (ORCID: https://orcid.org/0000-0002-4793-114X)
- Xiuju Wang (ORCID: https://orcid.org/0000-0002-9365-7225)
Institutions
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-06-20
- DOI
- https://doi.org/10.2174/0109298673363347250529114300
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00